Cargando…

Familial secondary hyperhidrosis associated with tumor necrosis factor–alpha inhibitor treatment

Detalles Bibliográficos
Autores principales:	Ikediobi, Ogechi, Chen, Yi-Chun, Shinkai, Kanade
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4809394/ https://www.ncbi.nlm.nih.gov/pubmed/27051797 http://dx.doi.org/10.1016/j.jdcr.2015.10.012

Ejemplares similares

Two Cases of Cutaneous Adverse Effects Induced by Tumor Necrosis Factor-Alpha Inhibitors
por: Masukawa, Ena, et al.
Publicado: (2021)

Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis
por: Callejas-Rubio, José Luis, et al.
Publicado: (2008)

Clinical features of tumor necrosis factor-α-inhibitor induced chilblain lupus: A case series
por: Shabeeb, Nadine, et al.
Publicado: (2021)

Case series of psoriasis associated with tumor necrosis factor-α inhibitors in children with chronic recurrent multifocal osteomyelitis
por: Campbell, Julie Ann, et al.
Publicado: (2018)

Pharmacogenomics of Allopurinol and Sulfamethoxazole/Trimethoprim: Case Series and Review of the Literature
por: Ikediobi, Ogechi, et al.
Publicado: (2021)

Alopecia secondary to anti-tumor necrosis factor-alpha therapy()
por: Ribeiro, Lara Beatriz Prata, et al.
Publicado: (2015)

A human inhibitor of tumor necrosis factor alpha
Publicado: (1988)

No impact of tumor necrosis-factor antagonists on the joint manifestations of sarcoidosis
por: Banse, Christopher, et al.
Publicado: (2013)

The clinical application of UGT1A1 pharmacogenetic testing: Gene-environment interactions
por: Marques, Sara Correia, et al.
Publicado: (2010)

The adverse drug reactions to tumor necrosis factor alpha inhibitor
por: Park, Hye-Kyung, et al.
Publicado: (2014)

Tumor Necrosis Factor Alpha Inhibitor-Induced Acute Pancreatitis
por: Werlang, Monia E., et al.
Publicado: (2017)

Mechanisms of Tumor Necrosis Factor-Alpha Inhibitor-Induced Systemic Lupus Erythematosus
por: Yen, Chung-Yang, et al.
Publicado: (2022)

Appearance of ANCA – associated vasculitis under Tumor necrosis factor-alpha inhibitors treatment
por: Reitblat, Tatiana, et al.
Publicado: (2013)

Tumor necrosis factor alpha inhibitors and demyelinating disease: what is behind it?
por: Kucharz, Eugeniusz Józef, et al.
Publicado: (2021)

Machine learning analysis of primary hyperhidrosis for classification of hyperhidrosis type and prediction of compensatory hyperhidrosis
por: Hyun, Kwan Yong, et al.
Publicado: (2023)

Safety of tumor necrosis factor-alpha inhibitors for treatment of ankylosing spondylitis: A meta-analysis
por: Ma, Zeren, et al.
Publicado: (2017)

Psoriasis, Anti-Tumor Necrosis Factor Therapy, and Tuberculosis: Report of Three Challenging Cases and Literature Review
por: Solovan, Caius, et al.
Publicado: (2013)

Paradoxical Arthralgia Secondary to Anti-Tumor-Necrosis-Factor Alpha Therapy in Crohn’s Disease
por: Thurlapati, Aswani, et al.
Publicado: (2021)

Hyperhidrosis: Medical and Surgical Treatment
por: Stolman, Lewis P
Publicado: (2008)

Oxybutynin as an alternative treatment for hyperhidrosis
por: Delort, Sergio, et al.
Publicado: (2017)

The Effect of Tumor Necrosis Factor-Alpha Inhibitors on Uveitis in Patients with Ankylosing Spondylitis
por: Lee, Suhwan, et al.
Publicado: (2019)

Phytochemicals as inhibitors of tumor necrosis factor alpha and neuroinflammatory responses in neurodegenerative diseases
por: Zahedipour, Fatemeh, et al.
Publicado: (2022)

Tumor Necrosis Factor Alpha: Implications of Anesthesia on Cancers
por: Tseng, Wei-Cheng, et al.
Publicado: (2023)

Successful treatment of necrobiosis lipoidica and associated retinal vasculitis with tumor necrosis factor (TNF)-alpha inhibitor
por: Panse, Ketaki, et al.
Publicado: (2023)

Management of hyperhidrosis
por: Stashak, Anna-Bianca, et al.
Publicado: (2014)

Tumor Necrosis Factor Alpha Signaling and Organogenesis
por: You, Kai, et al.
Publicado: (2021)

Recommendation of using systemic anti-tumor necrosis factor-alpha for the treatment of noninfectious uveitis in Taiwan
por: Hwang, De-Kuang, et al.
Publicado: (2018)

To avoid compensatory hyperhidrosis after sympathetic surgery for craniofacial hyperhidrosis
por: Moon, Duk Hwan, et al.
Publicado: (2020)

Thoracoscopic sympathetic block to predict compensatory hyperhidrosis in primary hyperhidrosis
por: Lee, June, et al.
Publicado: (2021)

Genome-wide linkage analysis of families with primary hyperhidrosis
por: Schote, Andrea B., et al.
Publicado: (2020)

Familial Aggregation of High Tumor Necrosis Factor Alpha Levels in Systemic Lupus Erythematosus
por: Mangale, Dorothy, et al.
Publicado: (2013)

The Utility of Frequent Laboratory Monitoring for Patients on Tumor Necrosis Factor-Alpha Inhibitors in Dermatology
por: Houpe, Jessica E., et al.
Publicado: (2022)

Current treatment options for craniofacial hyperhidrosis
por: Wolosker, Nelson, et al.
Publicado: (2020)

Regional risk of tuberculosis and viral hepatitis with tumor necrosis factor-alpha inhibitor treatment: A systematic review
por: Jahnich, Nina, et al.
Publicado: (2023)

Alternative Surgical Methods in Patients with Recurrent Palmar Hyperhidrosis and Compensatory Hyperhidrosis
por: Jung, Hee Suk, et al.
Publicado: (2018)

New sympathicotomy for prevention of severe compensatory hyperhidrosis in patients with primary hyperhidrosis
por: Han, Jung Wook, et al.
Publicado: (2020)

TUMOR NECROSIS FACTOR-ALPHA IN PATIENTS WITH ALOPECIA AREATA
por: Kasumagic-Halilovic, Emina, et al.
Publicado: (2011)

Glaucomatous neurodegeneration: An eye on tumor necrosis factor-alpha
por: Agarwal, Renu, et al.
Publicado: (2012)

Intermittent Hypothermia with Hyperhidrosis
Publicado: (1943)

Robotic Sympathectomy for Hyperhidrosis
por: Ravendran, Kapilraj, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o2ll9k3i7d9m6tqnlhl77l5fi4